On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...